NOVEL HIV PROTEASE INHIBITORS
The present invention provides novel HIV protease inhibitors containing substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster, wherein the charge of each borane, carborane or metallacarborane cluster is 0, -1 or -2; the number of borane, carborane or met...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KRAL VLADIMIR KONVALINKA JAN BODEM JOCHEN PREJDOVA JANA POKORNA JANA GRUNER BOHUMIR KRAUSSLICH HANS GEORG KOZISEK MILAN CIGLER PETR PLESEK JAROMIR LEPSIK MARTIN |
| description | The present invention provides novel HIV protease inhibitors containing substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster, wherein the charge of each borane, carborane or metallacarborane cluster is 0, -1 or -2; the number of borane, carborane or metallacarborane clusters in the inhibitor molecule is 1 to 9, and the carborane clusters in metallacarborane inhibitors are coordinated to transition metal atom, selected from the group containing cobalt, iron, nickel and ruthenium. In the cluster can be present heteroatoms as nitrogen, phosphorus, silicon, germanium, tin and sulphur. Pharmaceutical compositions containing these inhibitors and their use, both in vitro and in vivo. They are characterized by high effectivity and stability. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20060129396A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20060129396A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20060129396A3</originalsourceid><addsrcrecordid>eNrjZJD18w9z9VHw8AxTCAjyD3F1DHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGBmYGhkaWxpZmjsbEqQIAIBMiFQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL HIV PROTEASE INHIBITORS</title><source>esp@cenet</source><creator>KRAL VLADIMIR ; KONVALINKA JAN ; BODEM JOCHEN ; PREJDOVA JANA ; POKORNA JANA ; GRUNER BOHUMIR ; KRAUSSLICH HANS GEORG ; KOZISEK MILAN ; CIGLER PETR ; PLESEK JAROMIR ; LEPSIK MARTIN</creator><creatorcontrib>KRAL VLADIMIR ; KONVALINKA JAN ; BODEM JOCHEN ; PREJDOVA JANA ; POKORNA JANA ; GRUNER BOHUMIR ; KRAUSSLICH HANS GEORG ; KOZISEK MILAN ; CIGLER PETR ; PLESEK JAROMIR ; LEPSIK MARTIN</creatorcontrib><description>The present invention provides novel HIV protease inhibitors containing substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster, wherein the charge of each borane, carborane or metallacarborane cluster is 0, -1 or -2; the number of borane, carborane or metallacarborane clusters in the inhibitor molecule is 1 to 9, and the carborane clusters in metallacarborane inhibitors are coordinated to transition metal atom, selected from the group containing cobalt, iron, nickel and ruthenium. In the cluster can be present heteroatoms as nitrogen, phosphorus, silicon, germanium, tin and sulphur. Pharmaceutical compositions containing these inhibitors and their use, both in vitro and in vivo. They are characterized by high effectivity and stability.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061215&DB=EPODOC&CC=KR&NR=20060129396A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061215&DB=EPODOC&CC=KR&NR=20060129396A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KRAL VLADIMIR</creatorcontrib><creatorcontrib>KONVALINKA JAN</creatorcontrib><creatorcontrib>BODEM JOCHEN</creatorcontrib><creatorcontrib>PREJDOVA JANA</creatorcontrib><creatorcontrib>POKORNA JANA</creatorcontrib><creatorcontrib>GRUNER BOHUMIR</creatorcontrib><creatorcontrib>KRAUSSLICH HANS GEORG</creatorcontrib><creatorcontrib>KOZISEK MILAN</creatorcontrib><creatorcontrib>CIGLER PETR</creatorcontrib><creatorcontrib>PLESEK JAROMIR</creatorcontrib><creatorcontrib>LEPSIK MARTIN</creatorcontrib><title>NOVEL HIV PROTEASE INHIBITORS</title><description>The present invention provides novel HIV protease inhibitors containing substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster, wherein the charge of each borane, carborane or metallacarborane cluster is 0, -1 or -2; the number of borane, carborane or metallacarborane clusters in the inhibitor molecule is 1 to 9, and the carborane clusters in metallacarborane inhibitors are coordinated to transition metal atom, selected from the group containing cobalt, iron, nickel and ruthenium. In the cluster can be present heteroatoms as nitrogen, phosphorus, silicon, germanium, tin and sulphur. Pharmaceutical compositions containing these inhibitors and their use, both in vitro and in vivo. They are characterized by high effectivity and stability.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD18w9z9VHw8AxTCAjyD3F1DHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGBmYGhkaWxpZmjsbEqQIAIBMiFQ</recordid><startdate>20061215</startdate><enddate>20061215</enddate><creator>KRAL VLADIMIR</creator><creator>KONVALINKA JAN</creator><creator>BODEM JOCHEN</creator><creator>PREJDOVA JANA</creator><creator>POKORNA JANA</creator><creator>GRUNER BOHUMIR</creator><creator>KRAUSSLICH HANS GEORG</creator><creator>KOZISEK MILAN</creator><creator>CIGLER PETR</creator><creator>PLESEK JAROMIR</creator><creator>LEPSIK MARTIN</creator><scope>EVB</scope></search><sort><creationdate>20061215</creationdate><title>NOVEL HIV PROTEASE INHIBITORS</title><author>KRAL VLADIMIR ; KONVALINKA JAN ; BODEM JOCHEN ; PREJDOVA JANA ; POKORNA JANA ; GRUNER BOHUMIR ; KRAUSSLICH HANS GEORG ; KOZISEK MILAN ; CIGLER PETR ; PLESEK JAROMIR ; LEPSIK MARTIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20060129396A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KRAL VLADIMIR</creatorcontrib><creatorcontrib>KONVALINKA JAN</creatorcontrib><creatorcontrib>BODEM JOCHEN</creatorcontrib><creatorcontrib>PREJDOVA JANA</creatorcontrib><creatorcontrib>POKORNA JANA</creatorcontrib><creatorcontrib>GRUNER BOHUMIR</creatorcontrib><creatorcontrib>KRAUSSLICH HANS GEORG</creatorcontrib><creatorcontrib>KOZISEK MILAN</creatorcontrib><creatorcontrib>CIGLER PETR</creatorcontrib><creatorcontrib>PLESEK JAROMIR</creatorcontrib><creatorcontrib>LEPSIK MARTIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KRAL VLADIMIR</au><au>KONVALINKA JAN</au><au>BODEM JOCHEN</au><au>PREJDOVA JANA</au><au>POKORNA JANA</au><au>GRUNER BOHUMIR</au><au>KRAUSSLICH HANS GEORG</au><au>KOZISEK MILAN</au><au>CIGLER PETR</au><au>PLESEK JAROMIR</au><au>LEPSIK MARTIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL HIV PROTEASE INHIBITORS</title><date>2006-12-15</date><risdate>2006</risdate><abstract>The present invention provides novel HIV protease inhibitors containing substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster, wherein the charge of each borane, carborane or metallacarborane cluster is 0, -1 or -2; the number of borane, carborane or metallacarborane clusters in the inhibitor molecule is 1 to 9, and the carborane clusters in metallacarborane inhibitors are coordinated to transition metal atom, selected from the group containing cobalt, iron, nickel and ruthenium. In the cluster can be present heteroatoms as nitrogen, phosphorus, silicon, germanium, tin and sulphur. Pharmaceutical compositions containing these inhibitors and their use, both in vitro and in vivo. They are characterized by high effectivity and stability.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_KR20060129396A |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | NOVEL HIV PROTEASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T00%3A11%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KRAL%20VLADIMIR&rft.date=2006-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20060129396A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |